Treatment of inflammatory bowel disease: A role for hypnotherapy?

International Journal of Clinical and Experimental Hypnosis

Volumn 56, Issue 3, 2008, Pages 306-317

  Miller, Vivien ^a   Whorwell, Peter J ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; MESALAZINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; ENTERITIS; FEMALE; FOLLOW UP; HUMAN; HYPNOSIS; MALE; QUALITY OF LIFE; REMISSION; TREATMENT FAILURE;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AZATHIOPRINE; COLITIS, ULCERATIVE; COMBINED MODALITY THERAPY; CROHN DISEASE; FEMALE; HUMANS; HYPNOSIS; IMMUNOSUPPRESSIVE AGENTS; MALE; MESALAMINE; MIDDLE AGED; QUALITY OF LIFE; RECURRENCE; SUGGESTION; YOUNG ADULT;

EID: 45949108551     PISSN: 00207144     EISSN: 17445183     Source Type: Journal    
DOI: 10.1080/00207140802041884     Document Type: Article

References (38)

1. Abela, M. B. (2000). Hypnotherapy for Crohn's disease. A promising complementary/alternative therapy. Integrated Medicine, 2, 127-131.
2. Anton, P. A. (1999). Stress and mind-body impact on the course of inflammatory bowel diseases. Seminars in Gastrointestinal Diseases, 10, 14-19.
3. Bamias, G., Nyce, M. R., De La Rue, S. A., & Cominelli, F. (2005). New concepts in the pathophysiology of inflammatory bowel disease. Annals of Internal Medicine, 143, 895-904.
4. Bhatia, V., & Tandon, R. K. (2005). Stress and the gastrointestinal tract. Journal of Gastroenterology and Hepatology, 20, 332-339.
5. Calvert, E. L., Houghton, L. A., Cooper, P., Morris, J., & Whorwell, P. J. (2002). Longterm improvement in functional dyspepsia using hypnotherapy. Gastroenterology, 123, 1778-1785.
6. Chiarioni, G., Vantini, I., De Iorio, F., & Benini, L. (2006). Prokinetic effect of gut-oriented hypnosis on gastric emptying. Alimentary & Pharmacological Therapy, 23, 1241-1249.
7. Colgan, S. M., Faragher, E. B., & Whorwell, P. J. (1988). Controlled trial of hypnotherapy in relapse prevention of duodenal ulceration. Lancet, 1(8598), 1299-1300.
8. Fleshner, M., & Laudenslager, M. L. (2004). Psychoneuroimmunology: Then and now. Behavioral and Cognitive Neuroscience Reviews, 3, 114-130.
9. Freyberger, H., Kunsebeck, H. W., Lempa, W., Wellmann, W., & Avenarius, H. J. (1985). Psychotherapeutic interventions in alexithymic patients. With special regard to ulcerative colitis and Crohn patients. Psychotherapy and Psychosomatics, 44, 72-81.
10. Fry, L., Mason, A. A., & Pearson, R. S. (1964). Effect of hypnosis on allergic skin responses in asthma and hay-fever. British Medical Journal, 1(5391), 1145-1148.
11. Gonsalkorale, W. M., Miller, V., Afzal, A., & Whorwell, P. J. (2003). Long term benefits of hypnotherapy for irritable bowel syndrome. Gut, 52, 1623-1629.
12. Gruzelier, J. H. (2002). A review of the impact of hypnosis, relaxation, guided imagery and individual differences on aspects of immunity and health. Stress, 5, 147-163.
13. Gruzelier, J., Smith, F., Nagy, A., & Henderson, D. (2001). Cellular and humoral immunity, mood and exam stress: The influences of self-hypnosis and personality predictors. International Journal of Psychophysiology, 42, 55-71.
14. Hart, A., & Kamm, M. A. (2002). Review article: Mechanisms of initiation and perpetuation of gut inflammation by stress. Alimentary & Pharmacological Therapy, 16, 2017-2028.
15. Jantschek, G., Zeitz, M., Pritsch, M., Wirsching, M., Klor, H. U., Studt, H. H., et al. (1998). Effect of psychotherapy on the course of Crohn's disease. Results of the German prospective multicenter psychotherapy treatment study on Crohn's disease. German Study Group on Psychosocial Intervention in Crohn's Disease. Scandinavian Journal of Gastroenterology, 33, 1289-1296.
16. Jones, H., Cooper, P., Miller, V., Brooks, N., & Whorwell, P. J. (2006). Treatment of noncardiac chest pain: A controlled trial of hypnotherapy. Gut, 55, 1403-1408.
17. Karush, A., Daniels, G. E., O'Connor, J. F., & Stern, L. O. (1968). The response to psychotherapy in chronic ulcerative colitis. I. Pretreatment factors. Psychosomatic Medicine, 30, 255-276.
18. Karush, A., Daniels, G. E., O'Connor, J. F., & Stern, L. O. (1969). The response to psychotherapy in chronic ulcerative colitis. II. Factors arising from the therapeutic situation. Psychosomatic Medicine, 31, 201-226.
19. Kiecolt-Glaser, J. K., Marucha, P. T., Atkinson, C., & Glaser, R. (2001). Hypnosis as a modulator of cellular immune dysregulation during acute stress. Journal of Consulting and Clinical Psychology, 69, 674-682.
20. Klein, K. B., & Spiegel, D. (1989). Modulation of gastric acid secretion by hypnosis. Gastroenterology, 96, 1383-1387.
21. Lea, R., Houghton, L. A., Calvert, E. L., Larder, S., Gonsalkorale, W. M., Whelan, V., et al. (2003). Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome. Alimentary & Pharmacological Therapy, 17, 635-642.
22. Locke, S. E., Ransil, B. J., Zachariae, R., Molay, F., Tollins, K., Covino, N. A., et al. (1994). Effect of hypnotic suggestion on the delayed-type hypersensitivity response. Journal of the American Medical Association, 272, 47-52.
23. Maunder, R. G. (2005). Evidence that stress contributes to inflammatory bowel disease: Evaluation, synthesis, and future directions. Inflammatory Bowel Disease, 11, 600-608.
24. Mawdsley, J. E., & Rampton, D. S. (2005). Psychological stress in IBD: New insights into pathogenic and therapeutic implications. Gut, 54, 1481-1491.
25. Milne, B., Joachim, G., & Niedhardt, J. (1986). A stress management programme for inflammatory bowel disease patients. Journal of Advanced Nursing, 11, 561-567.
26. Munkholm, P., Loftus, E. V., Jr., Reinacher-Schick, A., Kornbluth, A., Mittmann, U., & Esendal, B. (2006). Prevention of colorectal cancer in inflammatory bowel disease: Value of screening and 5-aminosalicylates. Digestion, 73, 11-19.
27. Rainville, P., Duncan, G. H., Price, D. D., Carrier, B., & Bushnell, M. C. (1997). Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science, 277(5328), 968-971.
28. Ray, O. (2004). The revolutionary health science of psychoendoneuroimmunology: A new paradigm for understanding health and treating illness. Annals of the New York Academy of Science, 1032, 35-51.
29. Schafer, D. W. (1997). Hypnosis and the treatment of ulcerative colitis and Crohn's disease. American Journal of Clinical Hypnosis, 40, 111-117.
30. Schwarz, S. P., & Blanchard, E. B. (1991). Evaluation of a psychological treatment for inflammatory bowel disease. Behavioral Research Therapy, 29, 167-177.
31. Shetty, A., Kalantzis, C., Polymeros, D., Vega, R., Abraham, S., & Forbes, A. (2004). Hypnotherapy for inflammatory bowel disease: A randomized, placebo controlled trial. Gut, 53(Suppl VI), A226.
32. Simren, M., Ringstrom, G., Bjornsson, E. S., & Abrahamsson, H. (2004). Treatment with hypnotherapy reduces the sensory and motor component of the gastrocolonic response in irritable bowel syndrome. Psychosomatic Medicine, 66, 233-238.
33. Wen, Z., & Fiocchi, C. (2004). Inflammatory bowel disease: Autoimmune or immunemediated pathogenesis? Clinical Developments in Immunology, 11(3-4), 195-204.
34. Whorwell, P. J. (2006). Effective management of irritable bowel syndrome - The Manchester Model. International Journal of Clinical and Experimental Hypnosis, 54, 21-26.
35. Whorwell, P. J., Houghton, L. A., Taylor, E. E., & Maxton, D. G. (1992). Physiological effects of emotion: Assessment via hypnosis. Lancet, 340(8811), 69-72.
36. Whorwell, P. J., Prior, A., & Faragher, E. B. (1984). Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet, 2(8414), 1232-1234.
37. Young, Y., & Abreu, M. T. (2006). Advances in the pathogenesis of inflammatory bowel disease. Curr. Gastroenterology Rep., 8(6), 470-477.
38. Zachariae, R., Bjerring, P., & Arendt-Nielsen, L. (1989). Modulation of type I immediate and type IV delayed immunoreactivity using direct suggestion and guided imagery during hypnosis. Allergy, 44, 537-542.